Inventor · disambiguated record
J. William Langston
Also filed as: LANGSTON J W · LANGSTON J WILLIAM
6 granted patents·15 pending applications·75 citations·filing 2006–2017
82Inventor score
Top patents by PatentIndex Score
21 records- 0190US10233422B2Pluripotent cell lines and methods of use thereofPARKINSONS INST·Filed 2016·Granted Mar 19, 2019·13 cites·19 claims
- 0288US8669048B2Pluripotent cell lines and methods of use thereofREIJO PERA RENEE ANN·Filed 2009·Granted Mar 11, 2014·20 cites·16 claims
- 0388US7718677B2Methods and compositions for reduction of side effects of therapeutic treatmentsPARKINSON S INST·Filed 2008·Granted May 18, 2010·41 cites·22 claims
- 0470US9464273B2Pluripotent cell lines and methods of use thereofPARKINSON'S INST·Filed 2013·Granted Oct 11, 2016·1 cites·21 claims
- 0560US2010166735A1Methods and compositions for reduction of side effects of therapeutic treatmentsQUIK MARYKA·Filed 2009·Application pending·0 cites
- 0660US2010159004A1Methods and compositions for reduction of side effects of therapeutic treatmentsQUIK MARYKA·Filed 2009·Application pending·0 cites
- 0760US2010196463A1Methods and compositions for reduction of side effects of therapeutic treatmentsQUIK MARYKA·Filed 2009·Application pending·0 cites
- 0860US2010158895A1Methods and compositions for reduction of side effects of therapeutic treatmentsQUIK MARYKA·Filed 2009·Application pending·0 cites
- 0959US2010029723A1Methods and compositions for reduction of side effects of therapeutic treatmentsQUIK MARYKA·Filed 2009·Application pending·0 cites
- 1057US2012052053A1Compositions and methods for the treatment of altered alpha-synuclein functionMANNING-BOG AMY B·Filed 2009·Application pending·0 cites
- 1150US2016235732A1Methods and compositions for reduction of side effects of therapeutic treatmentsPARKINSON'S INST·Filed 2015·Application pending·0 cites
- 1249US2015044193A1COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTIONNEURALTUS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1347US2011077276A1Methods and Compositions for Reduction of Side Effects of Therapeutic TreatmentsQUIK MARYKA·Filed 2010·Application pending·0 cites
- 1445US2009010894A1Methods and systems for identifying compounds that modulate alpha-synuclein aggregationPARKINSON S INST·Filed 2008·Application pending·0 cites
- 1543US10631772B2Diagnosis of neurodegenerative disordersPARKINSONS INST·Filed 2017·Granted Apr 28, 2020·0 cites·19 claims
- 1643US2007214509A1Methods and systems for identifying compounds that modulate alpha-synuclein aggregationPARKINSON S INST·Filed 2006·Application pending·0 cites
- 1741US9622669B2Diagnosis of neurodegenerative disordersLANGSTON J WILLIAM·Filed 2009·Granted Apr 18, 2017·0 cites·9 claims
- 1840US2015037257A1Compositions and methods for high-throughput screening in skin fibroblasts with an alpha-synuclein triplicationMAK SALLY·Filed 2012·Application pending·0 cites
- 1938US2012214241A1Zinc finger nuclease modification of leucine rich repeat kinase 2 (lrrk2) mutant fibroblasts and ipscsLAGANIERE JOSEE·Filed 2011·Application pending·0 cites
- 2037US2018110768A1Methods and compositions for reduction of side effects of therapeutic treatmentsPARKINSONS INST·Filed 2017·Application pending·0 cites
- 2136US2019085394A1Refining diagnosis and treatment of complex multi-symptom neurological disordersPARKINSONS INST·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →